GENERIC NAME OF THE MEDICINAL PRODUCT:

Gliclazide Modified Release Tablets IP 30mg
Gliclazide Modified Release Tablets IP 60mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

a) Gliclazide Modified Release Tablets IP 30mg
Each uncoated tablet contains:
Gliclazide IP……………………30mg
Excipients………………………...q.s.

b) Gliclazide Modified Release Tablets IP 60mg
Each uncoated tablet contains:
Gliclazide IP……………………60mg
Excipients………………………...q.s.

THERAPEUTIC INDICATIONS:

Gliclazide is used to treat type 2 diabetes. It's a medicine known as a sulfonylurea. Sulfonylureas increase the amount of insulin your pancreas makes. This lowers your blood sugar.

CAUTION & WARNING:

CAUTION:
Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
SWALLOW WHOLE DO NOT CHEW OR CRUSH
SCHEDULE “H” Prescription Drug -Warning: Not to be sold by retail without the prescription of a Registered Medical Prescriber.

STORAGE & DOSAGE:

Storage: Protect form moisture at a temperature not exceeding 25˚C. Do not freeze. Keep the container tightly closed in order to protect from moisture.
Dosage: As directed by the Physician.

Gliclazide Modified Release Tablets 60mg Technical Specification:

Product Name:
Gliclazide Modified Release Tablets IP 
Brand Name: DIAGLIZID
Strength: 30mg, 60mg
Dosage Form: Tablets (Uncoated)
Route of Administration: Via oral Route
Packing: 30s, 90s, 100s
Pack Insert/Leaflet: PIL (Patient Information Leaflet)
Regulatory Documents: COA, MOA, Stability Studies, GMP
Therapeutic use: Antidiabetic, hypoglycemic
Indication: Gliclazide is used to treat type 2 diabetes. It’s a medicine known as a sulfonylurea. Sulfonylureas increase the amount of insulin your pancreas makes. This lowers your blood sugar.
Storage: Protect form moisture at a temperature not exceeding 25˚C.Do not freeze. Keep the container tightly closed in order to protect from moisture.

GENERIC NAME OF THE MEDICINAL PRODUCT:

  • Gliclazide Modified Release Tablets IP 30mg
  • Gliclazide Modified Release Tablets IP 60mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

  •  a) Gliclazide Modified Release Tablets IP 30mg
    Each uncoated tablet contains:
    Gliclazide IP……………………30mg
    Excipients…………………………q.s.
  •  b) Gliclazide Modified Release Tablets IP 60mg
    Each uncoated tablet contains:
    Gliclazide IP……………………60mg
    Excipients…………………………q.s.

THERAPEUTIC INDICATIONS:

  • Gliclazide is used to treat type 2 diabetes. It’s a medicine known as a sulfonylurea. Sulfonylureas increase the amount of insulin your pancreas makes. This lowers your blood sugar.

CAUTION & WARNING:

  • CAUTION:
    Read enclosed leaflet before use.
    Keep medicine out of reach of children.
    SWALLOW WHOLE DO NOT CHEW OR CRUSH
  • SCHEDULE “H” Prescription Drug -Warning: Not to be sold by retail without the prescription of a Registered Medical Prescriber.

STORAGE & DOSAGE:

  • Storage: Protect form moisture at a temperature not exceeding 25˚C. Do not freeze. Keep the container tightly closed in order to protect from moisture.
  • Dosage:  As directed by the Physician.

Introduction to Gliclazide Modified Release Tablets 60mg

Gliclazide Modified Release Tablets 60mg are an oral anti-diabetic medication widely prescribed for type 2 diabetes mellitus in adults. Belonging to the sulfonylurea class, gliclazide helps the pancreas release insulin, thereby controlling blood sugar levels. By managing glucose effectively, it reduces the risk of long-term complications like kidney failure, neuropathy, retinopathy, and cardiovascular disease.

The modified release (MR) formulation ensures a steady release of the medicine into the bloodstream, allowing for once-daily dosing, improved compliance, and smoother blood sugar control. This version is ideal for patients seeking stable glycemic control with fewer peaks and troughs in glucose levels.

Globally, the demand for Gliclazide Modified Release Tablets 60mg is on the rise due to increasing diabetes prevalence, especially in Asia, Africa, and the Middle East. India, with its strong pharmaceutical manufacturing base, plays a leading role in meeting global supply requirements, and Taj Pharma stands at the forefront of this mission.


Detailed Information for Importers, Exporters & Buyers

Taj Pharma, a leading Gliclazide Modified Release Tablets 60mg manufacturer and supplier in India, offers comprehensive export solutions tailored to the needs of global distributors, wholesalers, and PCD pharma franchise holders.

Regulatory Documentation Provided

Taj Pharma ensures complete regulatory compliance by supplying:

  • WHO-GMP Certificate

  • EU-GMP Approval (where applicable)

  • Certificate of Pharmaceutical Product (COPP)

  • Free Sale Certificate

  • Certificate of Analysis (COA)

  • Stability Data (Zone IV conditions available)

  • Batch Manufacturing Records

  • CTD / ACTD Dossier for product registration

Custom Packaging & Labeling

Taj Pharma offers customizable packaging options to suit importer requirements:

  • Alu-Alu or blister packs

  • HDPE or PET bottle packs

  • Branded or generic-neutral designs

  • Multilingual labeling compliant with importing country regulations

  • Tamper-proof, moisture-resistant packaging for extended shelf life

Shelf Life, Storage & Dosage Form

  • Shelf life: 24–36 months from manufacturing date

  • Storage: Store below 25°C, protect from moisture and direct sunlight

  • Dosage form: Film-coated, modified release tablets (60mg)

Export Certifications

Taj Pharma is accredited with multiple global certifications, including:

  • WHO-GMP (World Health Organization – Good Manufacturing Practice)

  • EU-GMP (European Union Good Manufacturing Practice)

  • ISO 9001:2015 Quality Management System

  • Halal Certification (upon request)

Target Countries & Export Markets

Taj Pharma exports Gliclazide Modified Release Tablets 60mg to over 40 countries:

  • Nigeria, Kenya, Ghana, Tanzania, Uganda

  • Vietnam, Philippines, Cambodia

  • UAE, Oman, Saudi Arabia, Qatar

  • Russia, Ukraine, Kazakhstan

  • Brazil, Chile, Peru

  • South Africa, Ethiopia, Sri Lanka


Why Taj Pharma is the Most Trusted Manufacturer, Supplier & Exporter

1. State-of-the-Art Manufacturing

Located in Vapi, Gujarat, Taj Pharma operates WHO-GMP and EU-GMP compliant manufacturing facilities equipped with:

  • Advanced production lines

  • Automated quality control systems

  • In-house R&D and stability testing laboratories

2. Affordable Pricing with Assured Quality

By optimizing production processes and raw material sourcing, Taj Pharma offers competitive export pricing without compromising on quality.

3. Global Presence & Supply Chain Support

Taj Pharma has a robust export network ensuring:

  • On-time delivery to multiple continents

  • Import registration assistance

  • Long-term supply agreements for consistent stock availability

4. Top 20 Countries Exporting

Nigeria, Kenya, South Africa, Vietnam, Philippines, Iraq, Libya, Uzbekistan, Ghana, Ethiopia, Yemen, Tanzania, Sri Lanka, Afghanistan, Myanmar, Nepal, Kazakhstan, Ecuador, Bangladesh, Dominican Republic


Technical Product Specification Table

Parameter Specification
Product Name Gliclazide Modified Release Tablets
Strength 60mg
Dosage Form Film-coated, modified release tablet
Therapeutic Category Anti-diabetic (Sulfonylurea)
Indication Type 2 Diabetes Mellitus
Packaging Options Blister packs, alu-alu strips, bottle packs
Shelf Life 24–36 months
Storage Conditions Below 25°C, protect from light and moisture
Manufacturing Standard WHO-GMP, EU-GMP
Regulatory Support COPP, CTD Dossier, COA, Stability Data
Origin India (Vapi, Gujarat)

If you are a pharmaceutical importer, distributor, or PCD franchise holder searching for a reliable Gliclazide Modified Release Tablets 60mg manufacturer in India, partner with Taj Pharma for world-class quality and dependable supply.

Contact Taj Pharma Today:
📧 export@tajpharma.com
🌐 www.tajpharma.com


Top 20 FAQs

1. What is Gliclazide Modified Release Tablets 60mg used for?
It’s used for managing blood sugar in type 2 diabetes patients.

2. How does it work?
It stimulates insulin secretion from the pancreas to lower blood sugar.

3. What is “modified release”?
It means the drug is released slowly over time for stable blood sugar control.

4. How should it be taken?
Once daily with breakfast, swallowed whole with water.

5. Can it be split or crushed?
No, as this will affect the slow-release mechanism.

6. What are common side effects?
Headache, diarrhea, mild hypoglycemia.

7. Can it cause low blood sugar?
Yes, especially if meals are skipped.

8. Is it safe during pregnancy?
Consult your doctor before use.

9. Can it be used with other diabetes medicines?
Yes, often combined with metformin.

10. What should I do if I miss a dose?
Take it as soon as possible unless near your next dose.

11. Who should not take it?
Patients with type 1 diabetes or severe kidney/liver disease.

12. Does Taj Pharma provide COPP and COA?
Yes, with every export order.

13. Can packaging be customized?
Yes, per importer’s needs.

14. Is Taj Pharma WHO-GMP certified?
Yes, fully compliant.

15. What’s the shelf life?
24–36 months.

16. Is it available for PCD Pharma Franchise?
Yes, across India.

17. Does Taj Pharma export to Africa?
Yes, to multiple African nations.

18. Where is it manufactured?
In Vapi, Gujarat, India.

19. Does it interact with other drugs?
Yes, always consult your physician.

20. How can I place an order?
Contact Taj Pharma via email or phone.